Gut bacteria strains could be the key to predicting cancer treatment success

FHS
March 7, 2024
2:46 am

Researchers discovered that gut microbiota strains can predict the effectiveness and adverse effects of immune checkpoint blockade (ICB) therapy in rare cancer patients.

Pioneers and Innovators in Psilocybin Treatments and How Big Pharma wants in on the Psychedelic Sector | Psychedelic Invest

Investorideas.com (https://www.investorideas.com) a global investor news source covering psilocybin and psychedelic health and wellness stocks releases a special news report featuring Kaya Holdings, Inc. (OTCQB:KAYS).

October 19, 2023

Name that Humira biosimilar: Inside the complicated process to brand the newest versions of AbbVie’s drug

Seven new drugs launched last week, all with resounding similarity — and all trying to capture a piece of the lucrative market for AbbVie’s Humira.

July 12, 2023

Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma

Patients with high-risk relapsed/refractory follicular lymphoma experienced statistically significant and clinically meaningful responses when treated with lisocabtagene maraleucel (liso-cel; Breyanzi) as second-line therapy, according to

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.